CENTENNIAL, Colo., June 17, 2019 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S. Food and Drug Administration's (FDA) approval ...

As was announced back in July, Apple partnered with Australian company Cochlear to develop the Nucleus 7, the first made for iPhone Cochlear implant, which is able to stream audio from a compatible ...

Australia-based company Cochlear on Wednesday debuted its latest hearing implant sound processor, the Nucleus 7, which was developed in cooperation with Apple to connect with and integrate sound from ...

Cochlear Limited announced yesterday the U.S. Food and Drug Administration clearance of three new products to be added to the company’s suite of hearing technology devices, all of which can connect to ...

Cochlear Ltd., of Sydney, received U.S. FDA approval for its Nucleus Profile Plus cochlear implant and the Nucleus 7 sound processor's new built-in connectivity, enabling direct streaming with ...

SYDNEY and COPENHAGEN, Denmark--(BUSINESS WIRE)--Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, and GN (GN.CO), the global leader in intelligent audio solutions, ...

The next-generation Cochlear Nucleus 6 Sound Processor is built on a completely new microchip platform with five times the processing power of the market-leading Nucleus 5 Sound Processor. The added ...